Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus

被引:36
作者
Knip, M
机构
[1] Univ Tampere, Sch Med, Dept Pediat, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Pediat, Tampere, Finland
[3] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland
基金
芬兰科学院; 英国医学研究理事会;
关键词
autoimmunity; autoantibodies; T-cell responses; prediabetes; prevention;
D O I
10.3109/07853899708999375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin-dependent diabetes mellitus (IDDM) is a chronic autoimmune disease with a subclinical prodromal period characterized by selective destruction of insulin-producing beta cells in the pancreatic islets, This process is assumed to be T-cell mediated, but the emergence of disease-associated autoantibodies into the peripheral circulation is usually the first noticeable sign of beta-cell autoimmunity in human IDDM. Recent observations have suggested that beta-cell autoimmunity may be induced in any individual at any time. There are also data indicating that such autoimmunity may have been initiated prenatally in some individuals. Only a proportion of those with signs of islet cell autoimmunity progress to clinical disease, and harmless beta-cell autoimmunity reflected by positivity for a single autoantibody specificity seems to appear without any relation to genetic IDDM susceptibility. One can hypothesize that in most subjects HLA-conferred protection against IDDM prevents the beta-cell process from progressing to a stage of destructive insulitis that may lead to clinical disease. Environmental factors may trigger initial beta-cell damage and subsequently accelerate the destructive process. Non-HLA genes may also be involved in the regulation of the progression rate. Prospective observations of prediabetic individuals have revealed that IDDM-associated autoantibodies tend to appear sequentially, and that those who progress to clinical disease mount a strong humoral immune response to most known disease-associated antigens, This indicates that the immune response associated with beta-cell destruction is not purely T-helper 1 biased. Antigen-specific immunotherapy may in the future offer effective measures to intervene in preclinical IDDM to prevent end-stage insulitis. Substantially more data have to be generated, however, on the mechanisms, efficacy and safety of such therapy before it is possible to judge its clinical applicability.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 34 条
[1]   Relationship between the incidence of childhood IDDM and the frequency of ICA positivity in nondiabetic children in the general population [J].
Adojaan, B ;
Knip, M ;
Vahasalo, P ;
Karjalainen, J ;
Kalits, O ;
Akerblom, HK .
DIABETES CARE, 1996, 19 (12) :1452-1454
[2]   Interaction of genetic and environmental factors in the pathogenesis of insulin-dependent diabetes mellitus [J].
Akerblom, HK ;
Knip, M ;
Hyoty, H ;
Reijonen, H ;
Virtanen, S ;
Savilahti, E ;
Ilonen, J .
CLINICA CHIMICA ACTA, 1997, 257 (02) :143-156
[3]   RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO GLUTAMATE-DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES [J].
ATKINSON, MA ;
KAUFMAN, DL ;
CAMPBELL, L ;
GIBBS, KA ;
SHAH, SC ;
BU, DF ;
ERLANDER, MG ;
TOBIN, AJ ;
MACLAREN, NK .
LANCET, 1992, 339 (8791) :458-459
[4]  
BELLO ID, 1996, DIABETES, V45, P795
[5]   COMBINED ANALYSIS OF AUTOANTIBODIES IMPROVES PREDICTION OF IDDM IN ISLET-CELL ANTIBODY-POSITIVE RELATIVES [J].
BINGLEY, PJ ;
CHRISTIE, MR ;
BONIFACIO, E ;
BONFANTI, R ;
SHATTOCK, M ;
FONTE, MT ;
BOTTAZZO, GF ;
GALE, EAM .
DIABETES, 1994, 43 (11) :1304-1310
[6]   Induction of autoimmune diabetes by oral administration of autoantigen [J].
Blanas, E ;
Carbone, FR ;
Allison, J ;
Miller, JFAP ;
Heath, WR .
SCIENCE, 1996, 274 (5293) :1707-1709
[7]   American Diabetes Association Scientific Sessions, 1995 - IDDM: Treatment and prevention [J].
Bloomgarden, ZT .
DIABETES CARE, 1996, 19 (01) :96-98
[8]   Islet cell autoantigens in type 1 diabetes [J].
Christie, MR .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (10) :827-838
[9]  
COOKE A, 1990, CURR TOP MICROBIOL, V164, P125
[10]   MATERNAL ENTEROVIRAL INFECTION DURING PREGNANCY AS A RISK FACTOR FOR CHILDHOOD IDDM - A POPULATION-BASED CASE-CONTROL STUDY [J].
DAHLQUIST, GG ;
IVARSSON, S ;
LINDBERG, B ;
FORSGREN, M .
DIABETES, 1995, 44 (04) :408-413